Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fidaxomicin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104418925A details resin chromatography and crystallization for fidaxomicin. This method reduces equipment costs and ensures high purity for reliable supply chains.
Novel purification method for Fidaxomicin using macroporous resins and polymer columns. Ensures >95% purity and scalable production for pharmaceutical partners.